Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Centre de Cancérologie de la Porte de Saint-Cloud (CCPSC) is a premier private oncology facility located in Boulogne-Billancourt, France, specializing in advanced radiotherapy and medical oncology. As a key member of the Amethyst Radiotherapy network, the center provides high-precision treatments including Volumetric Modulated Arc Therapy (VMAT) and Image-Guided Radiation Therapy (IGRT). The facility operates a multidisciplinary care model, integrating chemotherapy, immunotherapy, and supportive care services to treat a wide range of solid tumors and hematological conditions. CCPSC is also actively involved in clinical research, participating in international trials that offer patients access to innovative therapeutic protocols. The center serves as a critical regional hub for cancer treatment, maintaining strong collaborative links with major Parisian hospitals and research institutes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Centre de Cancérologie de la Porte de Saint-Cloud.